Masashi Miyaoka
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 11, 2022
The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP era.Atsushi Ito, Masashi Miyaoka, Sakura Tomita
|Mar 17, 2022
Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.Haruka Ikoma, Masashi Miyaoka, Shinichiro Hiraiwa
|Nov 02, 2021
AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.Masashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras
|Dec 20, 2019
Loss of nectin-3 expression as a marker of tumor aggressiveness in pancreatic neuroendocrine tumor.Kenichi Hirabayashi, Takuma Tajiri, Dustin E Bosch
Pageof 1
